Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Holiday: Gut Microbiota Modification for Refractory Crohn's Disease
NCT03476317Phase 2Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jul 2018
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluconazole in Crohn's disease, indeterminate colitis (IC), sponsored by Children's Hospital of Philadelphia. Started Jul 2018; status: completed.
02
Drugs
fluconazole
03
Conditions
Crohn's diseaseindeterminate colitis (IC)
Beyond the preview
Go deeper on NCT03476317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476317.